D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity

MS van der Knaap; B.C. Jacobs; GF Hoffmann; WL Nyhan; WO Renier; JAM Smeitink; Coriene Catsman - Berrevoets; O Hjalmarson; H Vallance; K Sugita; CM Bowe; JT Herrin; WJ Craigen; NRM Buist; DSK Brookfield; RA Chalmers

D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity

MS van der Knaap, B.C. Jacobs, GF Hoffmann, WL Nyhan, WO Renier, JAM Smeitink, Coriene Catsman - Berrevoets, O Hjalmarson, H Vallance, K Sugita, CM Bowe, JT Herrin, WJ Craigen, NRM Buist, DSK Brookfield, RA Chalmers

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

78 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	111-119
Number of pages	9
Journal	Annals of Neurology
Volume	45
Publication status	Published - 1999

Cite this

van der Knaap, MS ; Jacobs, B.C. ; Hoffmann, GF ; Nyhan, WL ; Renier, WO ; Smeitink, JAM ; Catsman - Berrevoets, Coriene ; Hjalmarson, O ; Vallance, H ; Sugita, K ; Bowe, CM ; Herrin, JT ; Craigen, WJ ; Buist, NRM ; Brookfield, DSK ; Chalmers, RA. / D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity. In: Annals of Neurology. 1999 ; Vol. 45. pp. 111-119.

@article{acce378e25bb4bb2b1a4fc353760a67f,

title = "D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity",

author = "{van der Knaap}, MS and B.C. Jacobs and GF Hoffmann and WL Nyhan and WO Renier and JAM Smeitink and {Catsman - Berrevoets}, Coriene and O Hjalmarson and H Vallance and K Sugita and CM Bowe and JT Herrin and WJ Craigen and NRM Buist and DSK Brookfield and RA Chalmers",

year = "1999",

language = "Undefined/Unknown",

volume = "45",

pages = "111--119",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley & Sons Inc.",

}

D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity. / van der Knaap, MS; Jacobs, B.C.; Hoffmann, GF; Nyhan, WL; Renier, WO; Smeitink, JAM; Catsman - Berrevoets, Coriene; Hjalmarson, O; Vallance, H; Sugita, K; Bowe, CM; Herrin, JT; Craigen, WJ; Buist, NRM; Brookfield, DSK; Chalmers, RA.

In: Annals of Neurology, Vol. 45, 1999, p. 111-119.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - D-2-hydroxyglutaric aciduria: biochemical marker or clinical disease entity

AU - van der Knaap, MS

AU - Jacobs, B.C.

AU - Hoffmann, GF

AU - Nyhan, WL

AU - Renier, WO

AU - Smeitink, JAM

AU - Catsman - Berrevoets, Coriene

AU - Hjalmarson, O

AU - Vallance, H

AU - Sugita, K

AU - Bowe, CM

AU - Herrin, JT

AU - Craigen, WJ

AU - Buist, NRM

AU - Brookfield, DSK

AU - Chalmers, RA

PY - 1999

Y1 - 1999

M3 - Article

VL - 45

SP - 111

EP - 119

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

ER -